Sort
16,300 grants matching “fatty liver disease”
Biomarker discovery for mitochondrial toxicants using metabolic footprinting
$373,821David Mark Hockenbery · Fred Hutchinson Cancer Research Center · R01 · FY2014 · ES
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging
$373,817Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2021 · AG
SIRT1 as a regulator of health and lifespan of mammals
$373,815David A. Sinclair · Harvard Medical School · R37 · FY2021 · AG
Cholesterol Ester Hydrolysis and cholesterol efflux
$373,750Shobha Ghosh · Virginia Commonwealth University · R01 · FY2011 · HL
Hepatic Cholesteryl Ester Metabolism and Cholesterol Elimination
$373,750Shobha Ghosh · Virginia Commonwealth University · R01 · FY2010 · HL
Cholesterol Ester Hydrolysis and cholesterol efflux
$373,750Shobha Ghosh · Virginia Commonwealth University · R01 · FY2010 · HL
Hepatic Cholesteryl Ester Metabolism and Cholesterol Elimination
$373,750Shobha Ghosh · Virginia Commonwealth University · R01 · FY2011 · HL
The impact of the unfolded protein responses on steatosis
$373,745Kirsten C Sadler Edepli · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · AA
Effect of Insulin and Propranolol on Post Burn Hypermetabolism and Inflammation
$373,725David N Herndon · University Of Texas Med Br Galveston · R01 · FY2010 · GM
Biomarkers for the two phase switches of mammalian hibernation
$373,672Sandra L Martin · University Of Colorado Denver · R01 · FY2011 · HL
A novel mechanism for ART-associated dyslipidemia and atherosclerosis
$373,523Changcheng Zhou · University Of Kentucky · R01 · FY2016 · HL
A novel mechanism for ART-associated dyslipidemia and atherosclerosis
$373,523Changcheng Zhou · University Of Kentucky · R01 · FY2017 · HL
A novel mechanism for ART-associated dyslipidemia and atherosclerosis
$373,523Changcheng Zhou · University Of Kentucky · R01 · FY2015 · HL
Regulation of hepatic lipid accumulation and insulin resistance
$373,500Jun Liu · Mayo Clinic Arizona · R01 · FY2017 · DK
Regulation of hepatic lipid accumulation and insulin resistance
$373,500Jun Liu · Mayo Clinic Arizona · R01 · FY2016 · DK
Ang II and Overnutrition and Insulin resistance in Cardiovascular Tissue
$373,462James Russell Sowers · University Of Missouri-Columbia · R01 · FY2012 · HL
Diet-Environment Interactions in Inflammation
$373,462Sanjay Rajagopalan · Ohio State University · R01 · FY2012 · ES
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$373,461Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2021 · AG
Exploring the pathophysiology and treatment of LCHADD retinopathy
$373,450Melanie B Gillingham · Oregon Health & Science University · R01 · FY2022 · EY
Cholesterol Ester Hydrolysis and cholesterol efflux
$373,438Shobha Ghosh · Virginia Commonwealth University · R01 · FY2009 · HL
Lipoproteins in Cardiovascular Biology and Pathology
$373,314Monty Krieger · Massachusetts Institute Of Technology · P01 · FY2009 · HL
Racial Differences in IFN Transcriptional Response
$373,299Daryl T Lau · Beth Israel Deaconess Medical Center · R01 · FY2008 · DK
Aging and Apoptosis
$373,157Brian A. Herman · University Of Texas Hlth Science Center · R37 · FY2008 · AG
Building Mouse Models of Metabolic Syndrome
$373,152Karen L Svenson · Jackson Laboratory · R01 · FY2011 · DK
Building Mouse Models of Metabolic Syndrome
$373,152Karen L Svenson · Jackson Laboratory · R01 · FY2014 · DK